title: Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients.
authors.affiliation: Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
authors.forename: T M
authors.initials: TM
authors.lastname: Fouad
authors.affiliation: Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
authors.forename: E
authors.initials: E
authors.lastname: de Azambuja
authors.affiliation: Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium hatem.azim@bordet.be.
authors.forename: H A
authors.initials: HA
authors.lastname: Azim
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans
chemical_list: D050071:Bone Density Conservation Agents